Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Shares Issued (2016 - 2025)

Historic Shares Issued for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $51000.0.

  • Enanta Pharmaceuticals' Shares Issued fell 2500.0% to $51000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $145000.0, marking a year-over-year decrease of 136.05%. This contributed to the annual value of $145000.0 for FY2025, which is 136.05% down from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Shares Issued stood at $51000.0 for Q3 2025, which was down 2500.0% from $94000.0 recorded in Q4 2024.
  • In the past 5 years, Enanta Pharmaceuticals' Shares Issued registered a high of $10.4 million during Q4 2021, and its lowest value of $28000.0 during Q2 2024.
  • Its 5-year average for Shares Issued is $1.8 million, with a median of $882000.0 in 2023.
  • Its Shares Issued has fluctuated over the past 5 years, first surged by 114957.98% in 2021, then plummeted by 9514.56% in 2023.
  • Enanta Pharmaceuticals' Shares Issued (Quarter) stood at $10.4 million in 2021, then tumbled by 89.18% to $1.1 million in 2022, then tumbled by 82.24% to $200000.0 in 2023, then tumbled by 53.0% to $94000.0 in 2024, then tumbled by 45.74% to $51000.0 in 2025.
  • Its last three reported values are $51000.0 in Q3 2025, $94000.0 for Q4 2024, and $68000.0 during Q3 2024.